Publicaciones
-
Serrano-Blanco A, Rubio-Valera M, Aznar I, Baladon L, Gibert K, Gracia Canales A, Kaskens L, Ortiz JM and Salvador-Carulla L.
In-patient costs of agitation and containment in a mental health catchment area.
BMC Psychiatry . 17(1): 212-212. Nº de citas: 23
-
Aznar I, Fernández A, Gil MM, Fajó-Pascual M, Moreno-Peral P, Peñarrubia-Teresa MT, Serrano-Blanco A, Sánchez-Niubó A, March-Pujol MA, Jové AM and Rubio-Valera M.
Initial medication non-adherence: prevalence and predictive factors in a cohort of 1.6 million primary care patients.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY . 83(6): 1328-1340. Nº de citas: 33
-
Mugica F, Nebot À, Bagherpour S, Baladon L and Serrano-Blanco A.
A model for continuous monitoring of patients with major depression in short and long term periods.
TECHNOLOGY AND HEALTH CARE . 25(3): 487-511. Nº de citas: 3
-
Luciano JV, Carlos Garcia Forero, Marta Cerdà Lafont, Peñarrubia-María MT, Fernández-Vergel R, JOSE MIGUEL RUIZ MARTIN, Rozadilla A, Sirvent Alierta, Elena, Santo Panero, Pilar, García Campayo, Javier, Serrano-Blanco A and Rubio-Valera M.
Functional Status, Quality of Life, and Costs Associated With Fibromyalgia Subgroups: A Latent Profile Analysis.
CLINICAL JOURNAL OF PAIN . 32(10): 829-840. Nº de citas: 33
-
Rubio-Valera M, Huerta-Ramos ME, Baladon L, Aznar-Lou I, Ortiz JM, Luciano JV, Roset-Arisso PN, Salvador-Carulla L, Villagrán JM, Mayoral F, Gracia A and Serrano-Blanco A.
Qualitative study of the agitation states and their characterization, and the interventions used to attend them
ACTAS ESPANOLAS DE PSIQUIATRIA . 44(5): 166-177. Nº de citas: 10
-
Burton C, Szentagotai Tatar A, McKinstry B, Matheson C, Matu S, Moldovan R, Macnab M, Farrow E, David D, Pagliari C, Serrano-Blanco A, Wolters M and Help4Mood Consortium.
Pilot randomised controlled trial of Help4Mood, an embodied virtual agent-based system to support treatment of depression
JOURNAL OF TELEMEDICINE AND TELECARE . 22(6): 348-355. Nº de citas: 71
-
Baladon L, Rubio-Valera M, Serrano-Blanco A, Palao DJ and Fernández A.
Gender differences in the impact of mental disorders and chronic physical conditions on health-related quality of life among non-demented primary care elderly patients
QUALITY OF LIFE RESEARCH . 25(6, SI): 1461-1474. Nº de citas: 14
-
de Araújo AA, Ribeiro SB, Dos Santos AC, Lemos TM, Medeiros CA, Guerra GC, de Araújo Júnior RF, Serrano-Blanco A and Rubio-Valera M.
Quality of Life and Hormonal, Biochemical, and Anthropometric Profile Between Olanzapine and Risperidone Users
PSYCHIATRIC QUARTERLY . 87(2): 293-304. Nº de citas: 5
-
Hargarter, L, Bergman, P, Conca, A, Serrano-Blanco A, Bitter, I, Bilankis, N and Schreiner, A.
Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia
EXPERT OPINION ON PHARMACOTHERAPY . 17(8): 1043-1053. Nº de citas: 24
-
Bellón JÁ, Conejo-Cerón S, Moreno-Peral P, King M, Nazareth I, Martín-Pérez C, Fernández-Alonso C, Rodríguez-Bayón A, Fernández A, Aiarzaguena JM, Montón-Franco C, Ibanez-Casas I, Rodríguez-Sánchez E, Ballesta-Rodríguez MI, Serrano-Blanco A, Gómez MC, LaFuente P, Muñoz-García MD, Mínguez-Gonzalo P, Araujo L, Palao D, Bully P, Zubiaga F, Navas-Campaña D, Mendive J, Aranda-Regules JM, Rodriguez-Morejón A, Salvador-Carulla L and Luna JD.
Intervention to Prevent Major Depression in Primary Care A Cluster Randomized Trial
ANNALS OF INTERNAL MEDICINE . 164(10): 656-665. Nº de citas: 26